Janus Henderson Group’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60M | Buy |
124,954
+21,709
| +21% | +$11.1M | 0.03% | 374 |
|
|
2025
Q4 | $58M | Buy |
103,245
+9,961
| +11% | +$5.65M | 0.03% | 385 |
|
|
2025
Q3 | $48M | Buy |
93,284
+36,954
| +66% | +$16.1M | 0.02% | 419 |
|
|
2025
Q2 | $17.7M | Sell |
56,330
-13,806
| -20% | -$4.14M | 0.01% | 591 |
|
|
2025
Q1 | $21.9M | Buy |
70,136
+929
| +1% | +$312K | 0.01% | 549 |
|
|
2024
Q4 | $23M | Buy |
69,207
+25,089
| +57% | +$8.51M | 0.01% | 548 |
|
|
2024
Q3 | $14.7M | Buy |
44,118
+4,023
| +10% | +$1.53M | 0.01% | 628 |
|
|
2024
Q2 | $16.5M | Sell |
40,095
-1,029
| -3% | -$407K | 0.01% | 605 |
|
|
2024
Q1 | $16.6M | Sell |
41,124
-2,810
| -6% | -$988K | 0.01% | 594 |
|
|
2023
Q4 | $13.5M | Buy |
43,934
+2,183
| +5% | +$589K | 0.01% | 620 |
|
|
2023
Q3 | $10.1M | Buy |
41,751
+4,477
| +12% | +$1.15M | 0.01% | 661 |
|
|
2023
Q2 | $8.95M | Buy |
37,274
+1,947
| +6% | +$404K | 0.01% | 707 |
|
|
2023
Q1 | $6.64M | Sell |
35,327
-31,013
| -47% | -$6.41M | ﹤0.01% | 799 |
|
|
2022
Q4 | $14.1M | Sell |
66,340
-69,056
| -51% | -$13.8M | 0.01% | 639 |
|
|
2022
Q3 | $21.3M | Buy |
135,396
+114,905
| +561% | +$18.3M | 0.01% | 658 |
|
|
2022
Q2 | $3.07M | Sell |
20,491
-1,668
| -8% | -$241K | ﹤0.01% | 948 |
|
|
2022
Q1 | $3.62M | Sell |
22,159
-7,142
| -24% | -$1.18M | ﹤0.01% | 1083 |
|
|
2021
Q4 | $6.38M | Buy |
29,301
+6,001
| +26% | +$1.26M | ﹤0.01% | 1012 |
|
|
2021
Q3 | $4.41M | Buy |
23,300
+1,163
| +5% | +$212K | ﹤0.01% | 1084 |
|
|
2021
Q2 | $3.91M | Sell |
22,137
-22,573
| -50% | -$3.9M | ﹤0.01% | 1114 |
|
|
2021
Q1 | $7.33M | Buy |
44,710
+14,772
| +49% | +$2.26M | ﹤0.01% | 947 |
|
|
2020
Q4 | $4.17M | Buy |
29,938
+8,450
| +39% | +$1.07M | ﹤0.01% | 996 |
|
|
2020
Q3 | $2.4M | Sell |
21,488
-5,244
| -20% | -$606K | ﹤0.01% | 1028 |
|
|
2020
Q2 | $2.49M | Buy |
26,732
+4,765
| +22% | +$405K | ﹤0.01% | 1002 |
|
|
2020
Q1 | $1.61M | Buy |
21,967
+10,204
| +87% | +$886K | ﹤0.01% | 1026 |
|
|
2019
Q4 | $989K | Buy |
11,763
+3,015
| +34% | +$233K | ﹤0.01% | 1223 |
|
|
2019
Q3 | $735K | Buy |
8,748
+493
| +6% | +$37.3K | ﹤0.01% | 1254 |
|
|
2019
Q2 | $540K | Sell |
8,255
-1,551
| -16% | -$89.4K | ﹤0.01% | 1259 |
|
|
2019
Q1 | $578K | Buy |
+9,806
| New | +$586K | ﹤0.01% | 1230 |
|
|
2018
Q3 | – | Sell |
-100,680
| Closed | -$4.33M | – | 1463 |
|
|
2018
Q2 | $4.33M | Buy |
+100,680
| New | +$4.07M | ﹤0.01% | 1040 |
|
Other funds holding MEDP
VPM
VCM
WA
Janus Henderson Group's MEDP Position: Q1 2026 in Review
Janus Henderson Group increased its Medpace (MEDP) stake by 21% in Q1 2026, buying an estimated $11.1M and bringing the position to 124,954 shares worth $60M. The position accounts for 0.03% of the portfolio, ranked #374.
Janus Henderson Group first reported a position in MEDP in Q2 2018 and has held it in 30 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Janus Henderson Group held 124,954 shares of Medpace worth $60M as of Q1 2026.
- Janus Henderson Group bought 21,709 Medpace shares in Q1 2026, an estimated $11.1M.
- Medpace made up 0.03% of Janus Henderson Group's portfolio in Q1 2026, its #374 holding.
- Janus Henderson Group first reported a position in Medpace in Q2 2018 and has held it in 30 quarters since.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.